Training Must Evolve to Better Serve Clinical Trial Professionals

Impacted by new technologies, a pandemic, and a host of other factors, the clinical trial landscape has inarguably undergone a dramatic transformation in 2020. “COVID-19 will permanently change everything about how we conduct and manage clinical trials,” says Michael Hamrell, PhD, RAC, FRAPS, CCRA, RQAP-GCP, FACRP, president of MORIAH Consultants, a Good Clinical Practice (GCP) consulting firm. Noting there was already a powerful movement toward the adoption of risk-based monitoring, Hamrell believes the trend has been accelerated due to the pandemic and the requirement to shut down live visits and isolate. “Companies have learned that effective oversight and monitoring can occur using virtual technology without a loss of confidence in the data,” he says. However, training might not be keeping up, worries Hamrell. “The focus over the last number of years has been on GCP training and making sure that the training is documented [with an emphasis on] and noting … Continue reading Training Must Evolve to Better Serve Clinical Trial Professionals